Meet Us

Leadership Team

Ponsi Trivisvavet

Ponsi Trivisvavet

CEO & Director

Julie Borlaug

Julie Borlaug

VP, Communications & PR

Dr. Catherine Feuillet

Dr. Catherine Feuillet

Chief Scientific Officer

Tom Halverson

Tom Halverson

Chief Financial Officer

Ponsi Trivisvavet

“Follow your heart and do the right thing.”

Ponsi Trivisvavet

CEO & Director

Ponsi brings global knowledge of the agriculture and seeds business and extensive management and operational skills to her leadership of the company. Prior to joining, she was COO at Indigo Agriculture, where she led the R&D operations and built the international businesses. Beforehand, Ponsi held a number of leadership and commercial roles at Syngenta, most recently as President of Syngenta Seeds North America and Regional Director of North America where she led $3.5bn business. Before Syngenta, Ponsi held positions with McKinsey & Company as well as with Merrill Lynch Phatra in Asia. She holds a MBA with distinction from Cornell University.

LinkedIn
Julie Borlaug

"This is not the time for tinkering; it is a time for transformation” – Ban Ki Moon

Julie Borlaug

VP, Communications & PR

Julie brings knowledge of external partnerships, communications and corporate relations, following in the footsteps of Dr. Norman E. Borlaug, her grandfather, to expand his mission to feed the world’s hungry. Prior joining Inari, Julie served as Associate Director of External Relations at the Borlaug Institute for International Agriculture.  She also handled strategic initiatives for corporate relations within AgriLife Research at Texas A&M. Julie serves on several boards and advisory councils including the Council for Agricultural Science & Technology (CAST), Community for Zero Hunger and Texas A&M Dallas Urban Agriculture Center Advisory Board. Julie received her MBA from the University of Dallas.

LinkedIn
Dr. Catherine Feuillet

“Never interrupt someone doing what you said couldn’t be done.” – A. Earhart

Dr. Catherine Feuillet

Chief Scientific Officer

Catherine brings deep experience in research innovation and extensive knowledge of genomics and wheat. Prior to Inari, she worked at Bayer CropScience where she was Head of Trait Research and at the French National Institute for Agricultural Research (INRA) where she was the Research Director leading the development of wheat genomics projects. Catherine is a co-founder of the International Wheat Genome Sequencing Consortium. She received her PhD from Paul Sabatier University in Toulouse. For her postdoctoral studies she served as an assistant professor at the University of Zurich, where she researched disease resistance genes and sought a better understanding of evolution of wheat and barley.

LinkedIn
Tom Halverson

“You miss 100 percent of the shots you never take.” — Wayne Gretzky

Tom Halverson

Chief Financial Officer

Tom brings years of corporate finance and capital markets experience in and around the agriculture value chain. Before joining Inari, he served as a managing director and head of the Agriculture, Clean Technology & Renewables investment banking group at Piper Jaffray, and was head of the group’s mergers and acquisitions practice. Prior to that, he worked in private equity and as a corporate-strategy consultant. Tom graduated from Harvard College and received an MBA from the Darden Graduate School of Business at the University of Virginia.

LinkedIn
Dr. Michael Kock

Dr. Michael Kock

VP, Innovation Catalyst

Matthew Perkins

Matthew Perkins

VP, Strategy

Jennifer Peterson

Jennifer Peterson

VP of People

Dr. Mark Stowers

Dr. Mark Stowers

Chief Operations Officer, President - North America

Dr. Michael Kock

“Progress is impossible without change, and those who cannot change their mind cannot change anything” – GB Shaw

Dr. Michael Kock

VP, Innovation Catalyst

Michael brings 20 years of experience creating and implementing holistic IP strategies to enable innovation. Before joining Inari, Michael was Head of Intellectual Property at Syngenta. He shaped major M&A, litigation, and licensing deals, and was instrumental in setting up a new industry licensing platform for seeds.  Prior to joining Syngenta, Michael spent 10 years at BASF. Michael received his PhD in Molecular Biology from Hamburg University, Germany and is a qualified European and Swiss Patent Attorney.

LinkedIn
Matthew Perkins

“Revolutions are judged not by what you destroy, but by what you create.” – Anon


Matthew Perkins

VP, Strategy

Matthew brings deep knowledge of digital agriculture and entrepreneurship. Matthew comes from The Climate Corporation after the company acquired Yield Pop, a seed analytics startup he founded that offers farmers unique insights into the performance of corn and soybean seeds. Prior to this, Matthew was Vegetables Portfolio Manager and Corporate Strategy Manager at Syngenta. Matthew began his career as a UK diplomat. He was responsible for a joint UK-China initiative on climate change launched by UK Prime Minister Tony Blair. Matthew has an MBA from Harvard University.

LinkedIn
Jennifer Peterson

“The future depends on what we do in the present.”, Mahatma Ghandi

Jennifer Peterson

VP of People

Jennifer has led global people strategy and operations for more than 15 years in private and public companies, focusing on business growth and transformations. Most recently she was SVP, Global Human Resources with Monotype where she grew the employee population by 300% over four years. Prior to that, she held positions with Intralinks, Kadient, Netegrity, and Putnam Investments. Jennifer holds a BA in Sociology from Franklin & Marshall College, and is pursuing her coaching certification with Coaches Training Institute (CTI).

LinkedIn
Dr. Mark Stowers

“The more you know, the less you need.” – Yves Chouinard

Dr. Mark Stowers

Chief Operations Officer, President - North America

Mark brings over 30 years experience in agriculture, operations and entrepreneurship. Before joining Inari, Mark was VP and Global Head of Research and Development of Limagrain. He led research and breeding at HM.Clause, a global leader in vegetable seeds. He has previously served at the senior executive level at Monsanto, POET, and Eastman Kodak. He has been the CEO or founder of five companies in sustainable agriculture, green chemistry and clean technology, securing over $2bn in financing. He holds a PhD in Microbiology from North Carolina State University, completed his postdoctoral studies at Cornell University and attended the Olin School of Business at Washington University – St. Louis.

LinkedIn

Board of Directors

Mike Mack

Mike Mack

Executive Chairman

Ponsi Trivisvavet

Ponsi Trivisvavet

Director

Dr. Robert Berendes

Dr. Robert Berendes

Director

Howard W. Buffett

Howard W. Buffett

Director

Mike Mack

 “Feeding the world and being environmentally and socially sustainable are not mutually exclusive.”

Mike Mack

Executive Chairman

Mike was Chief Executive Officer of Syngenta and an Executive Director of the Board from 2008 to 2015. Prior to Syngenta, Mike was President of the Global Paper Division of Imerys SA, a French mining and pigments company. Mike has also held various roles with Mead Corporation and served as Chairman and President of the Board of the Swiss-American Chamber of Commerce from 2009 to 2012. Mike has a degree in Economics from Kalamazoo College in Michigan, studied at the University of Strasbourg and has an MBA from Harvard University.

LinkedIn
Ponsi Trivisvavet

"Follow your heart and do the right thing."

Ponsi Trivisvavet

Director

Ponsi brings global knowledge of the agriculture and seeds business and extensive management and operational skills to her leadership of the company. Prior to joining, she was COO at Indigo Agriculture, where she led the R&D operations and built the international businesses. Beforehand, Ponsi held a number of leadership and commercial roles at Syngenta, most recently as President of Syngenta Seeds North America and Regional Director of North America where she led $3.5bn business. Before Syngenta, Ponsi held positions with McKinsey & Company as well as with Merrill Lynch Phatra in Asia. She holds a MBA with distinction from Cornell University.

LinkedIn
Dr. Robert Berendes

“Now is the time to fundamentally transform plant breeding.”

Dr. Robert Berendes

Director

Robert is a Venture Partner at Flagship Pioneering and Chairman of Indigo Ag and CiBO Technologies. He co-owns and serves as a partner of a-connect, a global talent management firm, where he leads their agribusiness, food and chemicals practice. He is also an Operating Director at Paine Schwartz Partners and serves on the Board of Directors of Verdesian Life Sciences and AgBiTech. Prior to this, he was Syngenta’s Global Head of Business Development and a member of the executive committee. Robert has a PhD in Biophysics from the Max-Planck-Institute for Biochemistry and Technical University of Munich and a Diploma in Chemistry from the University of Cologne.

LinkedIn
Howard W. Buffett

“Doing good does not excuse us from doing better.”

Howard W. Buffett

Director

Howard is a Professor at the College of Agricultural Sciences and Natural Resources at the University of Nebraska-Lincoln and Associate Professor at Columbia University’s School of International and Public Affairs. Howard previously served as the Executive Director of the Howard G. Buffett Foundation, where he oversaw the distribution of financial aid granted to strengthen food security. Prior to that, Howard oversaw agricultural economic redevelopment and stability programs in Afghanistan and Iraq for the US Department of Defense. He earned his MPA in Advanced Management and Finance from Columbia University.

LinkedIn
Bill Helman

Bill Helman

Director

Ignacio Martinez

Ignacio Martinez

Director

Rob Rosiello

Rob Rosiello

Director

Bill Helman

"It’s not how much you know, its’ how fast you learn."

Bill Helman

Director

Bill joined venture capital firm Greylock Partners in 1984 and served as Managing Partner from 2000-2013. Broadly experienced, he led Greylock’s investments in companies including Aveo Pharmaceuticals, Millennium Pharmaceuticals, Hyperion Software, Vertex Pharmaceuticals, UPromise, Reveal Imaging and Zipcar. Bill currently sits on the Ford Motor Company board of directors and has affiliations, past and present, with the boards of Dartmouth College, Harvard Management Company and the Isabella Stewart Gardner Museum. A graduate of Dartmouth, he also holds an MBA from the Harvard Business School.

Ignacio Martinez

“The only way of finding the limits of the possible is by going beyond them into the impossible.”

Ignacio Martinez

Director

Ignacio is the Co-Founder and founding CEO of Inari, and also a General Partner of Flagship Pioneering. Ignacio joined Flagship Pioneering in early 2013 to lead the sustainability activities of the firm, in addition to entrepreneurial activities in life sciences with a special interest on food, nutrition, and health. He is also the Co-Founder and founding CEO of CiBO Technologies, Invaio Sciences and Inarca Bio and a Founding Director of Indigo Agriculture. Prior to joining Flagship, Ignacio was a Managing Director of Syngenta Ventures. He holds an International MBA from Instituto de Empresain Spain and WHU Otto Beisheim School of Management in Germany.

LinkedIn
Rob Rosiello

“Breakthrough science and innovative technology can expand human possibilities”

Rob Rosiello

Director

Rob is Executive Partner and Chief Operating Officer at Flagship Pioneering where he oversees all aspects of Flagship’s processes for originating and developing new companies. Previously, Rob worked for 30 years at McKinsey & Company where he was a Senior Partner advised CEOs and boards of leading health care, technology, and consumer companies. He currently serves on the Board and Executive Committee of Catholic Charities of New York and the Central Selection Committee of the Morehead-Cain Foundation at the University of North Carolina. Rob received his MS in Economics from the London School of Economics and an MBA from Harvard University.

LinkedIn

SCIENTIFIC STRATEGY BOARD

Dr. George Church

Dr. George Church

Scientific Co-Founder and SSB Member

Dr. Steve Jacobsen

Dr. Steve Jacobsen

Scientific Co-Founder and SSB Member

Dr. Rodolphe Barrangou

Dr. Rodolphe Barrangou

Scientific Strategy Board, CRISPR System

Dr. Jennifer Doudna

Dr. Jennifer Doudna

Scientific Strategy Board, CRISPR Biology

Dr. George Church

“Finally we can align the ancient advantages of random mutations with modern desires for high quality and precision.”

Dr. George Church

Scientific Co-Founder and SSB Member

George comes to Inari to radically change crop improvement through the application of modern genome science. He is a Professor of Genetics at Harvard Medical School. George’s 1983 Harvard PhD included the first methods for direct genome sequencing, molecular multiplexing and barcoding, which led to the first genome sequence in 1994. His innovations have contributed to nearly all "next generation" DNA sequencing methods and his lab’s work on chip-DNA-synthesis, gene editing and stem cell engineering have formed the foundation for many innovative companies. In recognition of his achievements he has been elected to the National Academy of Sciences and the National Academy of Engineering.

LinkedIn
Dr. Steve Jacobsen

“I want to see our science make a difference in agriculture.”

Dr. Steve Jacobsen

Scientific Co-Founder and SSB Member

Steve is helping to develop commercial applications for technologies his lab has developed to regulate gene expression and modulate the epigenome to improve crop performance. He is a UCLA Professor in the Department of Molecular, Cell, and Developmental Biology and serves as a Howard Hughes Medical Institute (HHMI) Investigator. His lab has been instrumental in defining the mechanism of action of several gene silencing pathways in plants. In recognition of this achievement and others, he was elected to the National Academy of Sciences and the American Academy of Sciences. Steve earned his PhD at the University of Minnesota and postdoctoral studies at the California Institute of Technology.

LinkedIn
Dr. Rodolphe Barrangou

“The Ag landscape is shifting, and Inari has the ingredients necessary to define a better future”

Dr. Rodolphe Barrangou

Scientific Strategy Board, CRISPR System

Rodolphe is helping the company optimize CRISPR-Cas systems and their crop applications. He is the Todd R. Klaenhammer Distinguished Professor in Probiotics Research at North Carolina State University, where he focuses on the evolution and functions of CRISPR-Cas systems and their applications in bacteria. Rodolphe has received many awards for his work, including the 2016 Warren Alpert Foundation Prize, the 2016 Canada Gairdner International Award, the 2017 NAS Award in Molecular Biology, the 2018 NAS Prize in Food and Agriculture Sciences, and was elected into the US National Academy of Science in 2018.

Dr. Jennifer Doudna

“CRISPR has the potential to speed up new crop development by orders of magnitude.”

Dr. Jennifer Doudna

Scientific Strategy Board, CRISPR Biology

Jennifer is helping Inari optimize CRISPR technology for crop improvement applications. She is the Li Ka Shing Chancellor's Professor in Biomedical and Health at the University of California, Berkeley and has been a Howard Hughes Medical Institute (HHMI) Investigator since 1997. Jennifer’s lab studies many aspects of RNA biology and discovered the programmable nature of Cas nucleases. She has received many awards including a Packard Foundation Fellow Award, the American Association for the Advancement of Science Fellow Award and has been elected to the National Academy of Sciences, the American Academy of Arts and Sciences, Institute of Medicine of the National Academies and the Royal Society.

LinkedIn
Dr. Richard Flavell

Dr. Richard Flavell

Scientific Strategy Board, Plant Molecular Biology

Dr. Dirk Inze

Dr. Dirk Inze

Scientific Strategy Board, Plant Molecular Genetics

Dr. Zach Lippman

Dr. Zach Lippman

Scientific Strategy Board, Flower production

Dr. Richard Flavell

“Plant improvement through science is in urgent need to meet the needs of a healthy planet and people. Inari will be a significant contributor to this.”

Dr. Richard Flavell

Scientific Strategy Board, Plant Molecular Biology

Richard served as Interim CSO at Inari, helping the company become strategically positioned in plant science and plant breeding. His career has been associated with plant genomics, plant breeding, the development and deployment of plant transformation and the enhancement of agricultural traits in key crops. He has also served as Director of the John Innes Centre and Chief Scientific Officer of Ceres, Inc. He currently serves as Chair of the International Wheat Yield Partnership. His scientific accomplishments have earned him the position of Fellow of the Royal Society of London.

LinkedIn
Dr. Dirk Inze

Dr. Dirk Inze

Scientific Strategy Board, Plant Molecular Genetics

Dirk brings his expertise in the development of novel solutions to major crop production challenges. He is a Principal Investigator and Science Director at VIB, a life sciences research institute based in Belgium. His research aims to understand plant growth and his lab takes a systems biology approach to explore the mechanisms of leaf growth in Arabidopsis and maize – these discoveries have been applied to improve crop productivity and crop response to the environment. His scientific accomplishments have received several honors including the World Agriculture Prize in 2017 and the Körber Stiftung Prize.

LinkedIn
Dr. Zach Lippman

“Many joke I’m a plant doctor. It’s closer to the truth than most realize.”

Dr. Zach Lippman

Scientific Strategy Board, Flower production

Zach brings expertise in applying modern genome editing technology to crop improvement. Zach is the Jacob Goldfield Professor of Genetics at Cold Spring Harbor Laboratory and became a Howard Hughes Medical Investigator (HHMI) in 2018. A pioneer in the application of CRISPR technology to alter plant gene activity and create novel allelic variation, his research focuses on the process of flowering and flower production. He was a Finalist in Life Sciences for the 2018 Blavatnik National Awards, which honors outstanding scientists under the age of 42.


Leadership Team

Ponsi Trivisvavet

Ponsi Trivisvavet

CEO & Director

Julie Borlaug

Julie Borlaug

VP, Communications & PR

Ponsi Trivisvavet

“Follow your heart and do the right thing.”

Ponsi Trivisvavet

CEO & Director

Ponsi brings global knowledge of the agriculture and seeds business and extensive management and operational skills to her leadership of the company. Prior to joining, she was COO at Indigo Agriculture, where she led the R&D operations and built the international businesses. Beforehand, Ponsi held a number of leadership and commercial roles at Syngenta, most recently as President of Syngenta Seeds North America and Regional Director of North America where she led $3.5bn business. Before Syngenta, Ponsi held positions with McKinsey & Company as well as with Merrill Lynch Phatra in Asia. She holds a MBA with distinction from Cornell University.

LinkedIn
Julie Borlaug

"This is not the time for tinkering; it is a time for transformation” – Ban Ki Moon

Julie Borlaug

VP, Communications & PR

Julie brings knowledge of external partnerships, communications and corporate relations, following in the footsteps of Dr. Norman E. Borlaug, her grandfather, to expand his mission to feed the world’s hungry. Prior joining Inari, Julie served as Associate Director of External Relations at the Borlaug Institute for International Agriculture.  She also handled strategic initiatives for corporate relations within AgriLife Research at Texas A&M. Julie serves on several boards and advisory councils including the Council for Agricultural Science & Technology (CAST), Community for Zero Hunger and Texas A&M Dallas Urban Agriculture Center Advisory Board. Julie received her MBA from the University of Dallas.

LinkedIn
Dr. Catherine Feuillet

Dr. Catherine Feuillet

Chief Scientific Officer

Tom Halverson

Tom Halverson

Chief Financial Officer

Dr. Catherine Feuillet

“Never interrupt someone doing what you said couldn’t be done.” – A. Earhart

Dr. Catherine Feuillet

Chief Scientific Officer

Catherine brings deep experience in research innovation and extensive knowledge of genomics and wheat. Prior to Inari, she worked at Bayer CropScience where she was Head of Trait Research and at the French National Institute for Agricultural Research (INRA) where she was the Research Director leading the development of wheat genomics projects. Catherine is a co-founder of the International Wheat Genome Sequencing Consortium. She received her PhD from Paul Sabatier University in Toulouse. For her postdoctoral studies she served as an assistant professor at the University of Zurich, where she researched disease resistance genes and sought a better understanding of evolution of wheat and barley.

LinkedIn
Tom Halverson

“You miss 100 percent of the shots you never take.” — Wayne Gretzky

Tom Halverson

Chief Financial Officer

Tom brings years of corporate finance and capital markets experience in and around the agriculture value chain. Before joining Inari, he served as a managing director and head of the Agriculture, Clean Technology & Renewables investment banking group at Piper Jaffray, and was head of the group’s mergers and acquisitions practice. Prior to that, he worked in private equity and as a corporate-strategy consultant. Tom graduated from Harvard College and received an MBA from the Darden Graduate School of Business at the University of Virginia.

LinkedIn
Dr. Michael Kock

Dr. Michael Kock

VP, Innovation Catalyst

Matthew Perkins

Matthew Perkins

VP, Strategy

Dr. Michael Kock

“Progress is impossible without change, and those who cannot change their mind cannot change anything” – GB Shaw

Dr. Michael Kock

VP, Innovation Catalyst

Michael brings 20 years of experience creating and implementing holistic IP strategies to enable innovation. Before joining Inari, Michael was Head of Intellectual Property at Syngenta. He shaped major M&A, litigation, and licensing deals, and was instrumental in setting up a new industry licensing platform for seeds.  Prior to joining Syngenta, Michael spent 10 years at BASF. Michael received his PhD in Molecular Biology from Hamburg University, Germany and is a qualified European and Swiss Patent Attorney.

LinkedIn
Matthew Perkins

“Revolutions are judged not by what you destroy, but by what you create.” – Anon


Matthew Perkins

VP, Strategy

Matthew brings deep knowledge of digital agriculture and entrepreneurship. Matthew comes from The Climate Corporation after the company acquired Yield Pop, a seed analytics startup he founded that offers farmers unique insights into the performance of corn and soybean seeds. Prior to this, Matthew was Vegetables Portfolio Manager and Corporate Strategy Manager at Syngenta. Matthew began his career as a UK diplomat. He was responsible for a joint UK-China initiative on climate change launched by UK Prime Minister Tony Blair. Matthew has an MBA from Harvard University.

LinkedIn
Jennifer Peterson

Jennifer Peterson

VP of People

Dr. Mark Stowers

Dr. Mark Stowers

Chief Operations Officer, President - North America

Jennifer Peterson

“The future depends on what we do in the present.”, Mahatma Ghandi

Jennifer Peterson

VP of People

Jennifer has led global people strategy and operations for more than 15 years in private and public companies, focusing on business growth and transformations. Most recently she was SVP, Global Human Resources with Monotype where she grew the employee population by 300% over four years. Prior to that, she held positions with Intralinks, Kadient, Netegrity, and Putnam Investments. Jennifer holds a BA in Sociology from Franklin & Marshall College, and is pursuing her coaching certification with Coaches Training Institute (CTI).

LinkedIn
Dr. Mark Stowers

“The more you know, the less you need.” – Yves Chouinard

Dr. Mark Stowers

Chief Operations Officer, President - North America

Mark brings over 30 years experience in agriculture, operations and entrepreneurship. Before joining Inari, Mark was VP and Global Head of Research and Development of Limagrain. He led research and breeding at HM.Clause, a global leader in vegetable seeds. He has previously served at the senior executive level at Monsanto, POET, and Eastman Kodak. He has been the CEO or founder of five companies in sustainable agriculture, green chemistry and clean technology, securing over $2bn in financing. He holds a PhD in Microbiology from North Carolina State University, completed his postdoctoral studies at Cornell University and attended the Olin School of Business at Washington University – St. Louis.

LinkedIn

Board of Directors

Mike Mack

Mike Mack

Executive Chairman

Ponsi Trivisvavet

Ponsi Trivisvavet

Director

Mike Mack

 “Feeding the world and being environmentally and socially sustainable are not mutually exclusive.”

Mike Mack

Executive Chairman

Mike was Chief Executive Officer of Syngenta and an Executive Director of the Board from 2008 to 2015. Prior to Syngenta, Mike was President of the Global Paper Division of Imerys SA, a French mining and pigments company. Mike has also held various roles with Mead Corporation and served as Chairman and President of the Board of the Swiss-American Chamber of Commerce from 2009 to 2012. Mike has a degree in Economics from Kalamazoo College in Michigan, studied at the University of Strasbourg and has an MBA from Harvard University.

LinkedIn
Ponsi Trivisvavet

"Follow your heart and do the right thing."

Ponsi Trivisvavet

Director

Ponsi brings global knowledge of the agriculture and seeds business and extensive management and operational skills to her leadership of the company. Prior to joining, she was COO at Indigo Agriculture, where she led the R&D operations and built the international businesses. Beforehand, Ponsi held a number of leadership and commercial roles at Syngenta, most recently as President of Syngenta Seeds North America and Regional Director of North America where she led $3.5bn business. Before Syngenta, Ponsi held positions with McKinsey & Company as well as with Merrill Lynch Phatra in Asia. She holds a MBA with distinction from Cornell University.

LinkedIn
Dr. Robert Berendes

Dr. Robert Berendes

Director

Howard W. Buffett

Howard W. Buffett

Director

Dr. Robert Berendes

“Now is the time to fundamentally transform plant breeding.”

Dr. Robert Berendes

Director

Robert is a Venture Partner at Flagship Pioneering and Chairman of Indigo Ag and CiBO Technologies. He co-owns and serves as a partner of a-connect, a global talent management firm, where he leads their agribusiness, food and chemicals practice. He is also an Operating Director at Paine Schwartz Partners and serves on the Board of Directors of Verdesian Life Sciences and AgBiTech. Prior to this, he was Syngenta’s Global Head of Business Development and a member of the executive committee. Robert has a PhD in Biophysics from the Max-Planck-Institute for Biochemistry and Technical University of Munich and a Diploma in Chemistry from the University of Cologne.

LinkedIn
Howard W. Buffett

“Doing good does not excuse us from doing better.”

Howard W. Buffett

Director

Howard is a Professor at the College of Agricultural Sciences and Natural Resources at the University of Nebraska-Lincoln and Associate Professor at Columbia University’s School of International and Public Affairs. Howard previously served as the Executive Director of the Howard G. Buffett Foundation, where he oversaw the distribution of financial aid granted to strengthen food security. Prior to that, Howard oversaw agricultural economic redevelopment and stability programs in Afghanistan and Iraq for the US Department of Defense. He earned his MPA in Advanced Management and Finance from Columbia University.

LinkedIn
Bill Helman

Bill Helman

Director

Ignacio Martinez

Ignacio Martinez

Director

Bill Helman

"It’s not how much you know, its’ how fast you learn."

Bill Helman

Director

Bill joined venture capital firm Greylock Partners in 1984 and served as Managing Partner from 2000-2013. Broadly experienced, he led Greylock’s investments in companies including Aveo Pharmaceuticals, Millennium Pharmaceuticals, Hyperion Software, Vertex Pharmaceuticals, UPromise, Reveal Imaging and Zipcar. Bill currently sits on the Ford Motor Company board of directors and has affiliations, past and present, with the boards of Dartmouth College, Harvard Management Company and the Isabella Stewart Gardner Museum. A graduate of Dartmouth, he also holds an MBA from the Harvard Business School.

Ignacio Martinez

“The only way of finding the limits of the possible is by going beyond them into the impossible.”

Ignacio Martinez

Director

Ignacio is the Co-Founder and founding CEO of Inari, and also a General Partner of Flagship Pioneering. Ignacio joined Flagship Pioneering in early 2013 to lead the sustainability activities of the firm, in addition to entrepreneurial activities in life sciences with a special interest on food, nutrition, and health. He is also the Co-Founder and founding CEO of CiBO Technologies, Invaio Sciences and Inarca Bio and a Founding Director of Indigo Agriculture. Prior to joining Flagship, Ignacio was a Managing Director of Syngenta Ventures. He holds an International MBA from Instituto de Empresain Spain and WHU Otto Beisheim School of Management in Germany.

LinkedIn
Rob Rosiello

Rob Rosiello

Director

Rob Rosiello

“Breakthrough science and innovative technology can expand human possibilities”

Rob Rosiello

Director

Rob is Executive Partner and Chief Operating Officer at Flagship Pioneering where he oversees all aspects of Flagship’s processes for originating and developing new companies. Previously, Rob worked for 30 years at McKinsey & Company where he was a Senior Partner advised CEOs and boards of leading health care, technology, and consumer companies. He currently serves on the Board and Executive Committee of Catholic Charities of New York and the Central Selection Committee of the Morehead-Cain Foundation at the University of North Carolina. Rob received his MS in Economics from the London School of Economics and an MBA from Harvard University.

LinkedIn

SCIENTIFIC STRATEGY BOARD

Dr. George Church

Dr. George Church

Scientific Co-Founder and SSB Member

Dr. Steve Jacobsen

Dr. Steve Jacobsen

Scientific Co-Founder and SSB Member

Dr. George Church

“Finally we can align the ancient advantages of random mutations with modern desires for high quality and precision.”

Dr. George Church

Scientific Co-Founder and SSB Member

George comes to Inari to radically change crop improvement through the application of modern genome science. He is a Professor of Genetics at Harvard Medical School. George’s 1983 Harvard PhD included the first methods for direct genome sequencing, molecular multiplexing and barcoding, which led to the first genome sequence in 1994. His innovations have contributed to nearly all "next generation" DNA sequencing methods and his lab’s work on chip-DNA-synthesis, gene editing and stem cell engineering have formed the foundation for many innovative companies. In recognition of his achievements he has been elected to the National Academy of Sciences and the National Academy of Engineering.

LinkedIn
Dr. Steve Jacobsen

“I want to see our science make a difference in agriculture.”

Dr. Steve Jacobsen

Scientific Co-Founder and SSB Member

Steve is helping to develop commercial applications for technologies his lab has developed to regulate gene expression and modulate the epigenome to improve crop performance. He is a UCLA Professor in the Department of Molecular, Cell, and Developmental Biology and serves as a Howard Hughes Medical Institute (HHMI) Investigator. His lab has been instrumental in defining the mechanism of action of several gene silencing pathways in plants. In recognition of this achievement and others, he was elected to the National Academy of Sciences and the American Academy of Sciences. Steve earned his PhD at the University of Minnesota and postdoctoral studies at the California Institute of Technology.

LinkedIn
Dr. Rodolphe Barrangou

Dr. Rodolphe Barrangou

Scientific Strategy Board, CRISPR System

Dr. Jennifer Doudna

Dr. Jennifer Doudna

Scientific Strategy Board, CRISPR Biology

Dr. Rodolphe Barrangou

“The Ag landscape is shifting, and Inari has the ingredients necessary to define a better future”

Dr. Rodolphe Barrangou

Scientific Strategy Board, CRISPR System

Rodolphe is helping the company optimize CRISPR-Cas systems and their crop applications. He is the Todd R. Klaenhammer Distinguished Professor in Probiotics Research at North Carolina State University, where he focuses on the evolution and functions of CRISPR-Cas systems and their applications in bacteria. Rodolphe has received many awards for his work, including the 2016 Warren Alpert Foundation Prize, the 2016 Canada Gairdner International Award, the 2017 NAS Award in Molecular Biology, the 2018 NAS Prize in Food and Agriculture Sciences, and was elected into the US National Academy of Science in 2018.

Dr. Jennifer Doudna

“CRISPR has the potential to speed up new crop development by orders of magnitude.”

Dr. Jennifer Doudna

Scientific Strategy Board, CRISPR Biology

Jennifer is helping Inari optimize CRISPR technology for crop improvement applications. She is the Li Ka Shing Chancellor's Professor in Biomedical and Health at the University of California, Berkeley and has been a Howard Hughes Medical Institute (HHMI) Investigator since 1997. Jennifer’s lab studies many aspects of RNA biology and discovered the programmable nature of Cas nucleases. She has received many awards including a Packard Foundation Fellow Award, the American Association for the Advancement of Science Fellow Award and has been elected to the National Academy of Sciences, the American Academy of Arts and Sciences, Institute of Medicine of the National Academies and the Royal Society.

LinkedIn
Dr. Richard Flavell

Dr. Richard Flavell

Scientific Strategy Board, Plant Molecular Biology

Dr. Dirk Inze

Dr. Dirk Inze

Scientific Strategy Board, Plant Molecular Genetics

Dr. Richard Flavell

“Plant improvement through science is in urgent need to meet the needs of a healthy planet and people. Inari will be a significant contributor to this.”

Dr. Richard Flavell

Scientific Strategy Board, Plant Molecular Biology

Richard served as Interim CSO at Inari, helping the company become strategically positioned in plant science and plant breeding. His career has been associated with plant genomics, plant breeding, the development and deployment of plant transformation and the enhancement of agricultural traits in key crops. He has also served as Director of the John Innes Centre and Chief Scientific Officer of Ceres, Inc. He currently serves as Chair of the International Wheat Yield Partnership. His scientific accomplishments have earned him the position of Fellow of the Royal Society of London.

LinkedIn
Dr. Dirk Inze

Dr. Dirk Inze

Scientific Strategy Board, Plant Molecular Genetics

Dirk brings his expertise in the development of novel solutions to major crop production challenges. He is a Principal Investigator and Science Director at VIB, a life sciences research institute based in Belgium. His research aims to understand plant growth and his lab takes a systems biology approach to explore the mechanisms of leaf growth in Arabidopsis and maize – these discoveries have been applied to improve crop productivity and crop response to the environment. His scientific accomplishments have received several honors including the World Agriculture Prize in 2017 and the Körber Stiftung Prize.

LinkedIn
Dr. Zach Lippman

Dr. Zach Lippman

Scientific Strategy Board, Flower production

Dr. Zach Lippman

“Many joke I’m a plant doctor. It’s closer to the truth than most realize.”

Dr. Zach Lippman

Scientific Strategy Board, Flower production

Zach brings expertise in applying modern genome editing technology to crop improvement. Zach is the Jacob Goldfield Professor of Genetics at Cold Spring Harbor Laboratory and became a Howard Hughes Medical Investigator (HHMI) in 2018. A pioneer in the application of CRISPR technology to alter plant gene activity and create novel allelic variation, his research focuses on the process of flowering and flower production. He was a Finalist in Life Sciences for the 2018 Blavatnik National Awards, which honors outstanding scientists under the age of 42.


Leadership Team

Ponsi Trivisvavet

Ponsi Trivisvavet

CEO & Director

Ponsi Trivisvavet

“Follow your heart and do the right thing.”

Ponsi Trivisvavet

CEO & Director

Ponsi brings global knowledge of the agriculture and seeds business and extensive management and operational skills to her leadership of the company. Prior to joining, she was COO at Indigo Agriculture, where she led the R&D operations and built the international businesses. Beforehand, Ponsi held a number of leadership and commercial roles at Syngenta, most recently as President of Syngenta Seeds North America and Regional Director of North America where she led $3.5bn business. Before Syngenta, Ponsi held positions with McKinsey & Company as well as with Merrill Lynch Phatra in Asia. She holds a MBA with distinction from Cornell University.

LinkedIn
Julie Borlaug

Julie Borlaug

VP, Communications & PR

Julie Borlaug

"This is not the time for tinkering; it is a time for transformation” – Ban Ki Moon

Julie Borlaug

VP, Communications & PR

Julie brings knowledge of external partnerships, communications and corporate relations, following in the footsteps of Dr. Norman E. Borlaug, her grandfather, to expand his mission to feed the world’s hungry. Prior joining Inari, Julie served as Associate Director of External Relations at the Borlaug Institute for International Agriculture.  She also handled strategic initiatives for corporate relations within AgriLife Research at Texas A&M. Julie serves on several boards and advisory councils including the Council for Agricultural Science & Technology (CAST), Community for Zero Hunger and Texas A&M Dallas Urban Agriculture Center Advisory Board. Julie received her MBA from the University of Dallas.

LinkedIn
Dr. Catherine Feuillet

Dr. Catherine Feuillet

Chief Scientific Officer

Dr. Catherine Feuillet

“Never interrupt someone doing what you said couldn’t be done.” – A. Earhart

Dr. Catherine Feuillet

Chief Scientific Officer

Catherine brings deep experience in research innovation and extensive knowledge of genomics and wheat. Prior to Inari, she worked at Bayer CropScience where she was Head of Trait Research and at the French National Institute for Agricultural Research (INRA) where she was the Research Director leading the development of wheat genomics projects. Catherine is a co-founder of the International Wheat Genome Sequencing Consortium. She received her PhD from Paul Sabatier University in Toulouse. For her postdoctoral studies she served as an assistant professor at the University of Zurich, where she researched disease resistance genes and sought a better understanding of evolution of wheat and barley.

LinkedIn
Tom Halverson

Tom Halverson

Chief Financial Officer

Tom Halverson

“You miss 100 percent of the shots you never take.” — Wayne Gretzky

Tom Halverson

Chief Financial Officer

Tom brings years of corporate finance and capital markets experience in and around the agriculture value chain. Before joining Inari, he served as a managing director and head of the Agriculture, Clean Technology & Renewables investment banking group at Piper Jaffray, and was head of the group’s mergers and acquisitions practice. Prior to that, he worked in private equity and as a corporate-strategy consultant. Tom graduated from Harvard College and received an MBA from the Darden Graduate School of Business at the University of Virginia.

LinkedIn
Dr. Michael Kock

Dr. Michael Kock

VP, Innovation Catalyst

Dr. Michael Kock

“Progress is impossible without change, and those who cannot change their mind cannot change anything” – GB Shaw

Dr. Michael Kock

VP, Innovation Catalyst

Michael brings 20 years of experience creating and implementing holistic IP strategies to enable innovation. Before joining Inari, Michael was Head of Intellectual Property at Syngenta. He shaped major M&A, litigation, and licensing deals, and was instrumental in setting up a new industry licensing platform for seeds.  Prior to joining Syngenta, Michael spent 10 years at BASF. Michael received his PhD in Molecular Biology from Hamburg University, Germany and is a qualified European and Swiss Patent Attorney.

LinkedIn
Matthew Perkins

Matthew Perkins

VP, Strategy

Matthew Perkins

“Revolutions are judged not by what you destroy, but by what you create.” – Anon


Matthew Perkins

VP, Strategy

Matthew brings deep knowledge of digital agriculture and entrepreneurship. Matthew comes from The Climate Corporation after the company acquired Yield Pop, a seed analytics startup he founded that offers farmers unique insights into the performance of corn and soybean seeds. Prior to this, Matthew was Vegetables Portfolio Manager and Corporate Strategy Manager at Syngenta. Matthew began his career as a UK diplomat. He was responsible for a joint UK-China initiative on climate change launched by UK Prime Minister Tony Blair. Matthew has an MBA from Harvard University.

LinkedIn
Jennifer Peterson

Jennifer Peterson

VP of People

Jennifer Peterson

“The future depends on what we do in the present.”, Mahatma Ghandi

Jennifer Peterson

VP of People

Jennifer has led global people strategy and operations for more than 15 years in private and public companies, focusing on business growth and transformations. Most recently she was SVP, Global Human Resources with Monotype where she grew the employee population by 300% over four years. Prior to that, she held positions with Intralinks, Kadient, Netegrity, and Putnam Investments. Jennifer holds a BA in Sociology from Franklin & Marshall College, and is pursuing her coaching certification with Coaches Training Institute (CTI).

LinkedIn
Dr. Mark Stowers

Dr. Mark Stowers

Chief Operations Officer, President - North America

Dr. Mark Stowers

“The more you know, the less you need.” – Yves Chouinard

Dr. Mark Stowers

Chief Operations Officer, President - North America

Mark brings over 30 years experience in agriculture, operations and entrepreneurship. Before joining Inari, Mark was VP and Global Head of Research and Development of Limagrain. He led research and breeding at HM.Clause, a global leader in vegetable seeds. He has previously served at the senior executive level at Monsanto, POET, and Eastman Kodak. He has been the CEO or founder of five companies in sustainable agriculture, green chemistry and clean technology, securing over $2bn in financing. He holds a PhD in Microbiology from North Carolina State University, completed his postdoctoral studies at Cornell University and attended the Olin School of Business at Washington University – St. Louis.

LinkedIn

Board of Directors

Mike Mack

Mike Mack

Executive Chairman

Mike Mack

 “Feeding the world and being environmentally and socially sustainable are not mutually exclusive.”

Mike Mack

Executive Chairman

Mike was Chief Executive Officer of Syngenta and an Executive Director of the Board from 2008 to 2015. Prior to Syngenta, Mike was President of the Global Paper Division of Imerys SA, a French mining and pigments company. Mike has also held various roles with Mead Corporation and served as Chairman and President of the Board of the Swiss-American Chamber of Commerce from 2009 to 2012. Mike has a degree in Economics from Kalamazoo College in Michigan, studied at the University of Strasbourg and has an MBA from Harvard University.

LinkedIn
Ponsi Trivisvavet

Ponsi Trivisvavet

Director

Ponsi Trivisvavet

"Follow your heart and do the right thing."

Ponsi Trivisvavet

Director

Ponsi brings global knowledge of the agriculture and seeds business and extensive management and operational skills to her leadership of the company. Prior to joining, she was COO at Indigo Agriculture, where she led the R&D operations and built the international businesses. Beforehand, Ponsi held a number of leadership and commercial roles at Syngenta, most recently as President of Syngenta Seeds North America and Regional Director of North America where she led $3.5bn business. Before Syngenta, Ponsi held positions with McKinsey & Company as well as with Merrill Lynch Phatra in Asia. She holds a MBA with distinction from Cornell University.

LinkedIn
Dr. Robert Berendes

Dr. Robert Berendes

Director

Dr. Robert Berendes

“Now is the time to fundamentally transform plant breeding.”

Dr. Robert Berendes

Director

Robert is a Venture Partner at Flagship Pioneering and Chairman of Indigo Ag and CiBO Technologies. He co-owns and serves as a partner of a-connect, a global talent management firm, where he leads their agribusiness, food and chemicals practice. He is also an Operating Director at Paine Schwartz Partners and serves on the Board of Directors of Verdesian Life Sciences and AgBiTech. Prior to this, he was Syngenta’s Global Head of Business Development and a member of the executive committee. Robert has a PhD in Biophysics from the Max-Planck-Institute for Biochemistry and Technical University of Munich and a Diploma in Chemistry from the University of Cologne.

LinkedIn
Howard W. Buffett

Howard W. Buffett

Director

Howard W. Buffett

“Doing good does not excuse us from doing better.”

Howard W. Buffett

Director

Howard is a Professor at the College of Agricultural Sciences and Natural Resources at the University of Nebraska-Lincoln and Associate Professor at Columbia University’s School of International and Public Affairs. Howard previously served as the Executive Director of the Howard G. Buffett Foundation, where he oversaw the distribution of financial aid granted to strengthen food security. Prior to that, Howard oversaw agricultural economic redevelopment and stability programs in Afghanistan and Iraq for the US Department of Defense. He earned his MPA in Advanced Management and Finance from Columbia University.

LinkedIn
Bill Helman

Bill Helman

Director

Bill Helman

"It’s not how much you know, its’ how fast you learn."

Bill Helman

Director

Bill joined venture capital firm Greylock Partners in 1984 and served as Managing Partner from 2000-2013. Broadly experienced, he led Greylock’s investments in companies including Aveo Pharmaceuticals, Millennium Pharmaceuticals, Hyperion Software, Vertex Pharmaceuticals, UPromise, Reveal Imaging and Zipcar. Bill currently sits on the Ford Motor Company board of directors and has affiliations, past and present, with the boards of Dartmouth College, Harvard Management Company and the Isabella Stewart Gardner Museum. A graduate of Dartmouth, he also holds an MBA from the Harvard Business School.

Ignacio Martinez

Ignacio Martinez

Director

Ignacio Martinez

“The only way of finding the limits of the possible is by going beyond them into the impossible.”

Ignacio Martinez

Director

Ignacio is the Co-Founder and founding CEO of Inari, and also a General Partner of Flagship Pioneering. Ignacio joined Flagship Pioneering in early 2013 to lead the sustainability activities of the firm, in addition to entrepreneurial activities in life sciences with a special interest on food, nutrition, and health. He is also the Co-Founder and founding CEO of CiBO Technologies, Invaio Sciences and Inarca Bio and a Founding Director of Indigo Agriculture. Prior to joining Flagship, Ignacio was a Managing Director of Syngenta Ventures. He holds an International MBA from Instituto de Empresain Spain and WHU Otto Beisheim School of Management in Germany.

LinkedIn
Rob Rosiello

Rob Rosiello

Director

Rob Rosiello

“Breakthrough science and innovative technology can expand human possibilities”

Rob Rosiello

Director

Rob is Executive Partner and Chief Operating Officer at Flagship Pioneering where he oversees all aspects of Flagship’s processes for originating and developing new companies. Previously, Rob worked for 30 years at McKinsey & Company where he was a Senior Partner advised CEOs and boards of leading health care, technology, and consumer companies. He currently serves on the Board and Executive Committee of Catholic Charities of New York and the Central Selection Committee of the Morehead-Cain Foundation at the University of North Carolina. Rob received his MS in Economics from the London School of Economics and an MBA from Harvard University.

LinkedIn

SCIENTIFIC STRATEGY BOARD

Dr. George Church

Dr. George Church

Scientific Co-Founder and SSB Member

Dr. George Church

“Finally we can align the ancient advantages of random mutations with modern desires for high quality and precision.”

Dr. George Church

Scientific Co-Founder and SSB Member

George comes to Inari to radically change crop improvement through the application of modern genome science. He is a Professor of Genetics at Harvard Medical School. George’s 1983 Harvard PhD included the first methods for direct genome sequencing, molecular multiplexing and barcoding, which led to the first genome sequence in 1994. His innovations have contributed to nearly all "next generation" DNA sequencing methods and his lab’s work on chip-DNA-synthesis, gene editing and stem cell engineering have formed the foundation for many innovative companies. In recognition of his achievements he has been elected to the National Academy of Sciences and the National Academy of Engineering.

LinkedIn
Dr. Steve Jacobsen

Dr. Steve Jacobsen

Scientific Co-Founder and SSB Member

Dr. Steve Jacobsen

“I want to see our science make a difference in agriculture.”

Dr. Steve Jacobsen

Scientific Co-Founder and SSB Member

Steve is helping to develop commercial applications for technologies his lab has developed to regulate gene expression and modulate the epigenome to improve crop performance. He is a UCLA Professor in the Department of Molecular, Cell, and Developmental Biology and serves as a Howard Hughes Medical Institute (HHMI) Investigator. His lab has been instrumental in defining the mechanism of action of several gene silencing pathways in plants. In recognition of this achievement and others, he was elected to the National Academy of Sciences and the American Academy of Sciences. Steve earned his PhD at the University of Minnesota and postdoctoral studies at the California Institute of Technology.

LinkedIn
Dr. Rodolphe Barrangou

Dr. Rodolphe Barrangou

Scientific Strategy Board, CRISPR System

Dr. Rodolphe Barrangou

“The Ag landscape is shifting, and Inari has the ingredients necessary to define a better future”

Dr. Rodolphe Barrangou

Scientific Strategy Board, CRISPR System

Rodolphe is helping the company optimize CRISPR-Cas systems and their crop applications. He is the Todd R. Klaenhammer Distinguished Professor in Probiotics Research at North Carolina State University, where he focuses on the evolution and functions of CRISPR-Cas systems and their applications in bacteria. Rodolphe has received many awards for his work, including the 2016 Warren Alpert Foundation Prize, the 2016 Canada Gairdner International Award, the 2017 NAS Award in Molecular Biology, the 2018 NAS Prize in Food and Agriculture Sciences, and was elected into the US National Academy of Science in 2018.

Dr. Jennifer Doudna

Dr. Jennifer Doudna

Scientific Strategy Board, CRISPR Biology

Dr. Jennifer Doudna

“CRISPR has the potential to speed up new crop development by orders of magnitude.”

Dr. Jennifer Doudna

Scientific Strategy Board, CRISPR Biology

Jennifer is helping Inari optimize CRISPR technology for crop improvement applications. She is the Li Ka Shing Chancellor's Professor in Biomedical and Health at the University of California, Berkeley and has been a Howard Hughes Medical Institute (HHMI) Investigator since 1997. Jennifer’s lab studies many aspects of RNA biology and discovered the programmable nature of Cas nucleases. She has received many awards including a Packard Foundation Fellow Award, the American Association for the Advancement of Science Fellow Award and has been elected to the National Academy of Sciences, the American Academy of Arts and Sciences, Institute of Medicine of the National Academies and the Royal Society.

LinkedIn
Dr. Richard Flavell

Dr. Richard Flavell

Scientific Strategy Board, Plant Molecular Biology

Dr. Richard Flavell

“Plant improvement through science is in urgent need to meet the needs of a healthy planet and people. Inari will be a significant contributor to this.”

Dr. Richard Flavell

Scientific Strategy Board, Plant Molecular Biology

Richard served as Interim CSO at Inari, helping the company become strategically positioned in plant science and plant breeding. His career has been associated with plant genomics, plant breeding, the development and deployment of plant transformation and the enhancement of agricultural traits in key crops. He has also served as Director of the John Innes Centre and Chief Scientific Officer of Ceres, Inc. He currently serves as Chair of the International Wheat Yield Partnership. His scientific accomplishments have earned him the position of Fellow of the Royal Society of London.

LinkedIn
Dr. Dirk Inze

Dr. Dirk Inze

Scientific Strategy Board, Plant Molecular Genetics

Dr. Dirk Inze

Dr. Dirk Inze

Scientific Strategy Board, Plant Molecular Genetics

Dirk brings his expertise in the development of novel solutions to major crop production challenges. He is a Principal Investigator and Science Director at VIB, a life sciences research institute based in Belgium. His research aims to understand plant growth and his lab takes a systems biology approach to explore the mechanisms of leaf growth in Arabidopsis and maize – these discoveries have been applied to improve crop productivity and crop response to the environment. His scientific accomplishments have received several honors including the World Agriculture Prize in 2017 and the Körber Stiftung Prize.

LinkedIn
Dr. Zach Lippman

Dr. Zach Lippman

Scientific Strategy Board, Flower production

Dr. Zach Lippman

“Many joke I’m a plant doctor. It’s closer to the truth than most realize.”

Dr. Zach Lippman

Scientific Strategy Board, Flower production

Zach brings expertise in applying modern genome editing technology to crop improvement. Zach is the Jacob Goldfield Professor of Genetics at Cold Spring Harbor Laboratory and became a Howard Hughes Medical Investigator (HHMI) in 2018. A pioneer in the application of CRISPR technology to alter plant gene activity and create novel allelic variation, his research focuses on the process of flowering and flower production. He was a Finalist in Life Sciences for the 2018 Blavatnik National Awards, which honors outstanding scientists under the age of 42.


CREATING A NEW HORIZON

Through transformational plant breeding technology, we are creating a new horizon in agriculture that is more predictive, efficient, affordable, inclusive, and respectful of the environment.

Join our team contact us today